What Is Better for Older Patients With Acute Myeloid Leukemia?

被引：4
作者：
Ferrara, Felicetto [1 ]
Musto, Pellegrino [2 ]
机构：
[1] Cardarelli Hosp, Naples, Italy
[2] Ctr Riferimento Oncol Basilicata, Ist Ricovero & Cura Carattere Sci, Rionero In Vulture, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
LOW-DOSE CYTARABINE; MULTICENTER; AZACITIDINE; DECITABINE; TRIAL; UNFIT; CARE;
D O I：
10.1200/JCO.2012.45.2219
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：820 / 821
页数：2
相关论文
共 9 条
  • [1] A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment
    Burnett, Alan K.
    Milligan, Donald
    Prentice, Archie G.
    Goldstone, Anthony H.
    McMullin, Mary F.
    Hills, Robert K.
    Wheatley, Keith
    [J]. CANCER, 2007, 109 (06) : 1114 - 1124
  • [2] Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
    Fenaux, Pierre
    Mufti, Ghulam J.
    Hellstrom-Lindberg, Eva
    Santini, Valeria
    Gattermann, Norbert
    Germing, Ulrich
    Sanz, Guillermo
    List, Alan F.
    Gore, Steven
    Seymour, John F.
    Dombret, Herve
    Backstrom, Jay
    Zimmerman, Linda
    McKenzie, David
    Beach, C. L.
    Silverman, Lewis R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) : 562 - 569
  • [3] Hypomethylating Agents for the Treatment of Acute Myeloid Leukemia in the Elderly For All, None, or Which Patients?
    Ferrara, Felicetto
    Musto, Pellegrino
    [J]. CANCER, 2011, 117 (17) : 3879 - 3881
  • [4] Treatment of Unfit Patients With Acute Myeloid Leukemia: A Still Open Clinical Challenge
    Ferrara, Felicetto
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (01) : 10 - 16
  • [5] Treatment of older patients with acute myeloid leukaemia
    Ferrara, Felicetto
    [J]. LANCET, 2010, 376 (9757) : 1967 - 1968
  • [6] Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
    Kantarjian, Hagop M.
    Thomas, Xavier G.
    Dmoszynska, Anna
    Wierzbowska, Agnieszka
    Mazur, Grzegorz
    Mayer, Jiri
    Gau, Jyh-Pyng
    Chou, Wen-Chien
    Buckstein, Rena
    Cermak, Jaroslav
    Kuo, Ching-Yuan
    Oriol, Albert
    Ravandi, Farhad
    Faderl, Stefan
    Delaunay, Jacques
    Lysak, Daniel
    Minden, Mark
    Arthur, Christopher
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) : 2670 - 2677
  • [7] A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
    Luebbert, Michael
    Rueter, Bjoern H.
    Claus, Rainer
    Schmoor, Claudia
    Schmid, Mathias
    Germing, Ulrich
    Kuendgen, Andrea
    Rethwisch, Volker
    Ganser, Arnold
    Platzbecker, Uwe
    Galm, Oliver
    Brugger, Wolfram
    Heil, Gerhard
    Hackanson, Bjoern
    Deschler, Barbara
    Doehner, Konstanze
    Hagemeijer, Anne
    Wijermans, Pierre W.
    Doehner, Hartmut
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (03): : 393 - 401
  • [8] Azacitidine for the treatment of patients with acute myeloid leukemia
    Maurillo, Luca
    Venditti, Adriano
    Spagnoli, Alessandra
    Gaidano, Gianluca
    Ferrero, Dario
    Oliva, Esther
    Lunghi, Monia
    D'Arco, Alfonso M.
    Levis, Alessandro
    Pastore, Domenico
    Di Renzo, Nicola
    Santagostino, Alberto
    Pavone, Vincenzo
    Buccisano, Francesco
    Musto, Pellegrino
    [J]. CANCER, 2012, 118 (04) : 1014 - 1022
  • [9] Acute myeloid leukaemia in the elderly: a review
    Pollyea, Daniel A.
    Kohrt, Holbrook E.
    Medeiros, Bruno C.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (05) : 524 - 542
1